These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 14613420)

  • 41. Identification and management of oral isotretinoin use inconsistent with product labeling.
    Wert S
    Manag Care Interface; 2003 Mar; 16(3):41-3, 55. PubMed ID: 12715412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity (SMART) risk management program.
    Mendelsohn AB; Governale L; Trontell A; Seligman P
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):615-8. PubMed ID: 15892175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral isotretinoin: an analysis of its utilization in a managed care organization.
    Chen K; White TJ; Juzba M; Chang E
    J Manag Care Pharm; 2002; 8(4):272-7. PubMed ID: 14613420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.